Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
ArtMart Publications, Inc., and Arthur Nidetz
Polygram Holding, Inc.; Decca Music Group Limited, et al., In the Matter of
9068-8425 Quebec, INC. d/b/a Bio Lab, Cellu-Fight, and Quick Slim, and Jean-Francois Brochu
Physician Network Consulting, L.L.C.; Michael J. Taylor; Professional Orthopedic Services, Inc.; The Bone and Joint Clinic of Baton Rouge, Inc.; Baton Rouge Orthopaedic Clinic, L.L.C.; and Orthopaedic Surgery Associates of Baton Rouge, L.L.C
The Physician Network Consulting, L.L.C. of Baton Rouge Louisiana; Michael J. Taylor; Professional Orthopedic Services, Inc; The Bone and Joint Clinic of Baton Rouge, Inc.; Baton Rouge Orthopaedic Clinic, L.L.C.; and Orthopaedic Surgery Associates of Baton Rouge, L.L.C. settled charges that they entered into agreements to fix prices and other terms on which they would deal with United HealthCare of Louisiana, Inc., a health insurance company. Physician Network Consulting is an agent for Professional Orthopedic Services’ members.
Healthcare Claims Network, Inc., et al.
Carlton Press, Inc., et al.
Deer Creek Products, Inc.; Golden Age Products, Inc., a.k.a. Lakeside Products; and Michael Distephano., U.S. (For the FTC)
ICR Services, Inc., et al.
Global Vending Services, Inc., et al.
Rhino International, Inc., et al.
Safety Cell, Inc., et al.
Guess?, Inc., and Guess.com, Inc., In the Matter of
Americas Shopping Network, Inc., Consumer Services, Inc., et al.
Baxter International
Consent order requires divestiture of Baxter's Autoplex product line of Factor VIII inhibitors used in the treatment for hemophilia and the licensing of Immuno International AG's fibrin sealant, a biologic product in development to be used to control bleeding in surgical procedures. According to the complaint issued with the final order, the acquisition of Immuno International would tend to create a monopoly and increase Baxter's ability to unilaterally raise prices in the market for the research, manufacture and sale of biologic products derived from human blood plasma.